浏览全部资源
扫码关注微信
1.西南医科大学附属医院肾病内科/四川省肾脏疾病临床医学研究中心,四川 泸州 646000
2.西南医科大学附属中医医院中西医结合研究中心,四川 泸州 646000
3.西南医科大学附属中医医院肾病内科,四川 泸州 646000
硕士研究生。研究方向:肾脏病学。E-mail:964083717@qq.com
主任医师,教授,硕士生导师。研究方向:肾脏病学。E-mail:834300205@qq.com
纸质出版日期:2023-03-15,
收稿日期:2022-08-18,
修回日期:2023-01-20,
扫 描 看 全 文
邱莎,杨丽,谭睿陟等.黄柏酮对单侧输尿管梗阻模型小鼠肾间质纤维化及铁死亡的影响 Δ[J].中国药房,2023,34(05):554-559.
QIU Sha,YANG Li,TAN Ruizhi,et al.Effects of obacunone on renal interstitial fibrosis and ferroptosis in unilateral ureteral obstruction model mice[J].ZHONGGUO YAOFANG,2023,34(05):554-559.
邱莎,杨丽,谭睿陟等.黄柏酮对单侧输尿管梗阻模型小鼠肾间质纤维化及铁死亡的影响 Δ[J].中国药房,2023,34(05):554-559. DOI: 10.6039/j.issn.1001-0408.2023.05.08.
QIU Sha,YANG Li,TAN Ruizhi,et al.Effects of obacunone on renal interstitial fibrosis and ferroptosis in unilateral ureteral obstruction model mice[J].ZHONGGUO YAOFANG,2023,34(05):554-559. DOI: 10.6039/j.issn.1001-0408.2023.05.08.
目的
2
研究黄柏酮对单侧输尿管梗阻(UUO)模型小鼠肾间质纤维化的改善作用,并基于核转录因子红系2相关因子2(Nrf2)/谷胱甘肽过氧化物酶4(GPx4)信号通路介导的铁死亡探讨其作用机制。
方法
2
将30只小鼠随机分为假手术组、模型组、厄贝沙坦组(阳性对照,20 mg/kg)和黄柏酮低、高剂量组(10、40 mg/kg),每组6只。除假手术组外,其余各组小鼠均通过结扎单侧输尿管建立UUO模型。术后,给药组小鼠腹腔注射相应药物,假手术组、模型组小鼠腹腔注射等体积生理盐水,每天1次,连续7 d。检测小鼠血清中肌酐(Cr)、血尿素氮(BUN)水平,丙二醛(MDA)含量,总超氧化物歧化酶(T-SOD)活力和肾脏组织中Fe
2+
浓度;苏木精-伊红(HE)染色和Masson染色观察小鼠肾脏组织形态和纤维化情况;免疫组化法检测小鼠肾脏组织中纤连蛋白(Fn)、
α
-平滑肌肌动蛋白(
α
-SMA)、GPx4、Nrf2的表达,Western blot法和实时定量聚合酶链反应(RT-qPCR)检测小鼠肾脏组织中Fn、
α
-SMA、Nrf2、GPx4、溶质载体家族7成员11(SLC7A11)蛋白及mRNA的表达水平。
结果
2
与假手术组比较,模型组小鼠血清中Cr、BUN水平,MDA含量,肾脏组织中Fe
2+
浓度以及Fn、
α
-SMA蛋白和mRNA的表达水平均显著升高(
P
<0.05);血清中T-SOD活力,肾脏组织中Nrf2、GPx4、SLC7A11蛋白和mRNA的表达水平均显著降低(
P
<0.05);肾脏组织中肾小管扩张,胶原沉积明显,纤维条索较粗且着色较深,肾间质炎症细胞浸润明显。经黄柏酮干预后,小鼠血清或肾脏组织中上述指标(黄柏酮低剂量组SLC7A11 mRNA除外)水平均显著逆转(
P
<0.05),肾脏组织病理损伤、胶原沉积均有所减轻。
结论
2
黄柏酮可改善UUO模型小鼠的肾间质纤维化,具体作用机制可能与激活Nrf2/GPx4信号通路、抑制铁死亡有关。
OBJECTVE To study the improvement effects of obacunone on renal interstitial fibrosis (RIF) in unilateral ureteral obstruction (UUO) model mice, and to investigate its mechanism based on ferroptosis mediated by nuclear factor erythroid 2-related factor 2(Nrf2)/glutathione peroxidase 4 (GPx4) signaling pathway.
METHODS
2
Thirty mice were randomly divided into sham operation group, model group, irbesartan group (positive control, 20 mg/kg), obacunone low-dose and high-dose groups (10, 40 mg/kg), with 6 mice in each group. Except for sham operation group, UUO model was established by ligation of unilateral ureter in other groups. After operation, administration groups were given intraperitoneal injection of relevant medicine, and sham operation group and model group were given intraperitoneal injection of constant volume of normal saline, once a day, for 7 consecutive days. The levels of creatinine (Cr) and blood urea nitrogen (BUN), the content of malondialdehyde (MDA) and the activities of total superoxide dismutase (T-SOD) in serum and the concentration of Fe
2+
in renal tissue were all detected. HE staining and Masson staining were performed to observe the morphology and the fibrosis of renal tissues. Immunohisto- chemical staining was used to determine expressions of the fibronectin (Fn),
α
-smooth muscle actin (
α
-SMA), GPx4 and Nrf2 in renal tissue. Western blot and real-time quantitative polymerase chain reaction (RT-qPCR) were used to detect the protein and mRNA levels of Fn,
α
-SMA, Nrf2, GPx4 and SLC7A11 in the renal tissues.
RESULTS
2
Compared with sham operation group, serum levels of Cr and BUN, the concentration of Fe
2+
in renal tissue, the protein and mRNA levels of Fn and
α
-SMA in model group were increased significantly (
P
<0.05), while the activity of T-SOD in serum, protein and mRNA expressions of Nrf2, GPx4, SLC7A11 in kidney tissue were significantly decreased (
P
<0.05); in the kidney tissue, the renal tubules were dilated, the collagen deposition was obvious, the fibrous bands were thicker and darker, and the renal interstitial inflammatory cells infiltrated significantly. After intervened with obacunone, the levels of above indexes (except for mRNA expression of SLC7A11 in obacunone low-dose group) in serum and renal tissue were reversed significantly (
P
<0.05), and pathological damage and collagen deposition of kidney tissue were alleviated.
CONCLUSIONS
2
Obacunone can improve renal interstitial fibrosis of UUO model mice, the mechanism of which may be associated with activating the Nrf2/GPx4 pathway and then inhibiting ferroptosis to relieve RIF in UUO model mice.
黄柏酮肾间质纤维化单侧输尿管梗阻Nrf2/GPx4信号通路铁死亡
renal interstitial fibrosisunilateral ureteral obstructionNrf2/GPx4 signaling pathwayferroptosis
上海市肾内科临床质量控制中心专家组. 慢性肾脏病早期筛查、诊断及防治指南:2022年版[J]. 中华肾脏病杂志,2022,38(5):453-464.
BREYER M D,SUSZTAK K. The next generation of therapeutics for chronic kidney disease[J]. Nat Rev Drug Discov,2016,15(8):568-588.
DIXON S J,LEMBERG K M,LAMPRECHT M R,et al. Ferroptosis:an iron-dependent form of nonapoptotic cell death[J]. Cell,2012,149(5):1060-1072.
WANG J Y,LIU Y,WANG Y Q,et al. The cross-link between ferroptosis and kidney diseases[J]. Oxid Med Cell Longev,2021,2021:6654887.
GAO Y,HOU R,LIU F,et al. Obacunone causes sustained expression of MKP-1 thus inactivating p38 MAPK to suppress pro-inflammatory mediators through intracellular MIF[J]. J Cell Biochem,2018,119(1):837-849.
ZHOU J,WANG T Y,WANG H Z,et al. Obacunone attenuates high glucose-induced oxidative damage in NRK-52E cells by inhibiting the activity of GSK-3β[J]. Biochem Biophys Res Commun,2019,513(1):226-233.
MURTHY K N,JAYAPRAKASHA G K. Cytotoxicity of obacunone and obacunone glucoside in human prostate cancer cells involves Akt-mediated programmed cell death[J]. Toxicology,2015,329:88-97.
QIU Z W,HE J Z,SHAO G Y,et al. Obacunone retards renal cyst development in autosomal dominant polycystic kidney disease by activating NRF2[J]. Antioxidants (Basel),2021,11(1):38.
XU S M,CHEN W M,XIE Q F,et al. Obacunone activates the Nrf2-dependent antioxidant responses[J]. Protein Cell,2016,7(9):684-688.
BAI Y Q,WANG W W,WANG L,et al. Obacunone attenuates liver fibrosis with enhancing anti-oxidant effects of GPx4 and inhibition of EMT[J]. Molecules,2021,26(2):318.
LI J,DENG S H,LI J,et al. Obacunone alleviates ferroptosis during lipopolysaccharide-induced acute lung injury by upregulating Nrf2-dependent antioxidant responses[J]. Cell Mol Biol Lett,2022,27(1):29.
LIU M N,LIU T L,SHANG P J,et al. Acetyl-11-keto-β- boswellic acid ameliorates renal interstitial fibrosis via Klotho/TGF-β/Smad signalling pathway[J]. J Cell Mol Med,2018,22(10):4997-5007.
WEBSTER A C,NAGLER E V,MORTON R L,et al. Chronic kidney disease[J]. Lancet,2017,389(10075):1238-1252.
《中成药治疗优势病种临床应用指南》标准化项目组. 中成药治疗慢性肾脏病3~5期(非透析)临床应用指南:2020年[J]. 中国中西医结合杂志,2021,41(3):261-272.
程红新,杨晓萍,蒋雅红,等. 纤维连接蛋白在肾间质纤维化大鼠肾组织中的表达[J]. 中国组织工程研究,2012,16(31):5837-5842.
杨晓萍,张焕巧,赵瑾,等. 整合素连接激酶和α-平滑肌肌动蛋白的表达与肾间质纤维化关系的研究[J]. 北京医学,2007,29(10):600-603.
STOCKWELL B R,ANGELI J P F,BAYIR H,et al. Ferroptosis:a regulated cell death nexus linking metabolism,redox biology,and disease[J]. Cell,2017,171(2):273-285.
LI S W,ZHENG L S,ZHANG J,et al. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy[J]. Free Radic Biol Med,2021,162:435-449.
YANG L,GUO J,YU N,et al. Tocilizumab mimotope alleviates kidney injury and fibrosis by inhibiting IL-6 signaling and ferroptosis in UUO model[J]. Life Sci,2020,261:118487.
KERINS M J,OOI A. The roles of Nrf2 in modulating cellular iron homeostasis[J]. Antioxid Redox Signal,2018,29(17):1756-1773.
ZHANG J,LIU L,LI F R,et al. Treatment with catalpol protects against cisplatin-induced renal injury through Nrf2 and NF-κB signaling pathways[J]. Exp Ther Med,2020,20(4):3025-3032.
SHIN C S,MISHRA P,WATROUS J D,et al. The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility[J]. Nat Commun,2017,8:15074.
IMAI H,MATSUOKA M,KUMAGAI T,et al. Lipid peroxidation-dependent cell death regulated by GPx4 and ferroptosis[J]. Curr Top Microbiol Immunol,2017,403:143-170.
0
浏览量
6
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构